SARS-CoV-2 re-infection risk in Austria.

Stefan PilzAli ChakeriJohn P A IoannidisLukas RichterVerena Theiler-SchwetzChristian TrummerRobert KrauseFranz Allerberger

Published in: European journal of clinical investigation (2021)

We observed a relatively low re-infection rate of SARS-CoV-2 in Austria. Protection against SARS-CoV-2 after natural infection is comparable with the highest available estimates on vaccine efficacies. Further well-designed research on this issue is urgently needed for improving evidence-based decisions on public health measures and vaccination strategies.

Keyphrases

sars cov
public health
respiratory syndrome coronavirus
coronavirus disease